American International Group, Inc. 23and Me Holding Co. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.4 - $0.91 $800 - $1,820	2,001 Added 1.32%	153,309 $81,000
Q4 2023 Feb 13, 2024	BUY	$0.71 - $0.97 $13,960 - $19,073	19,663 Added 14.94%	151,308 $137,000
Q3 2023 Nov 13, 2023	BUY	$0.96 - $2.01 $6,293 - $13,177	6,556 Added 5.24%	131,645 $129,000
Q2 2023 Aug 04, 2023	BUY	$1.59 - $2.29 $712 - $1,025	448 Added 0.36%	125,089 $218,000
Q1 2023 May 12, 2023	BUY	$2.05 - $2.87 $5,086 - $7,120	2,481 Added 2.03%	124,641 $284,000
Q4 2022 Feb 10, 2023	SELL	$2.06 - $3.47 $916 - $1,544	-445 Reduced 0.36%	122,160 $263,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.12 $109,574 - $215,777	42,144 Added 52.38%	122,605 $351,000
Q2 2022 Aug 12, 2022	BUY	$2.19 - $3.98 $176,209 - $320,234	80,461 New	80,461 $200,000

159

100M

270K

349K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $75.3M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.